These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32243728)

  • 1. Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service.
    Tsai WC; Field L; Stewart S; Schultz M
    J Med Imaging Radiat Oncol; 2020 Jun; 64(3):379-384. PubMed ID: 32243728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis.
    Avolio PP; Lughezzani G; Paciotti M; Maffei D; Uleri A; Frego N; Hurle R; Lazzeri M; Saita A; Guazzoni G; Casale P; Buffi NM
    Urol Oncol; 2021 Dec; 39(12):832.e1-832.e7. PubMed ID: 34183255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
    Sathianathen NJ; Omer A; Harriss E; Davies L; Kasivisvanathan V; Punwani S; Moore CM; Kastner C; Barrett T; Van Den Bergh RC; Eddy BA; Gleeson F; Macpherson R; Bryant RJ; Catto JWF; Murphy DG; Hamdy FC; Ahmed HU; Lamb AD
    Eur Urol; 2020 Sep; 78(3):402-414. PubMed ID: 32444265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
    Greer MD; Brown AM; Shih JH; Summers RM; Marko J; Law YM; Sankineni S; George AK; Merino MJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2017 Feb; 45(2):579-585. PubMed ID: 27391860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer.
    Lokeshwar SD; Nguyen J; Rahman SN; Khajir G; Ho R; Ghabili K; Leapman MS; Weinreb JC; Sprenkle PC
    Urol Oncol; 2022 Sep; 40(9):407.e21-407.e27. PubMed ID: 35811206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of the prostate and targeted biopsy, Comparison of PIRADS and Gleason grading.
    Bastian-Jordan M
    J Med Imaging Radiat Oncol; 2018 Apr; 62(2):183-187. PubMed ID: 28990727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
    Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
    BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.
    Sonn GA; Fan RE; Ghanouni P; Wang NN; Brooks JD; Loening AM; Daniel BL; To'o KJ; Thong AE; Leppert JT
    Eur Urol Focus; 2019 Jul; 5(4):592-599. PubMed ID: 29226826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?
    Rico L; Blas L; Vitagliano G; Contreras P; Rios Pita H; Ameri C
    Urol Oncol; 2021 Jul; 39(7):431.e9-431.e13. PubMed ID: 33221259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology.
    Jia JB; Houshyar R; Verma S; Uchio E; Lall C
    Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
    Mathur S; O'Malley ME; Ghai S; Jhaveri K; Sreeharsha B; Margolis M; Zhong L; Maan H; Toi A
    Abdom Radiol (NY); 2019 Jan; 44(1):252-258. PubMed ID: 30032385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy.
    Nyk Ł; Tayara O; Ząbkowski T; Kryst P; Andrychowicz A; Malewski W
    BMC Urol; 2021 May; 21(1):82. PubMed ID: 34006281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy.
    Sun J; Zhang Z; OuYang J
    Urol Oncol; 2020 May; 38(5):401-409. PubMed ID: 31870724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.
    Johnson DC; Raman SS; Mirak SA; Kwan L; Bajgiran AM; Hsu W; Maehara CK; Ahuja P; Faiena I; Pooli A; Salmasi A; Sisk A; Felker ER; Lu DSK; Reiter RE
    Eur Urol; 2019 May; 75(5):712-720. PubMed ID: 30509763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.
    Al-Bayati M; Grueneisen J; Lütje S; Sawicki LM; Suntharalingam S; Tschirdewahn S; Forsting M; Rübben H; Herrmann K; Umutlu L; Wetter A
    Urol Int; 2018; 100(2):164-171. PubMed ID: 29393268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-gantry MRI guided prostate biopsy diagnosis of prostatitis and its relationship with PIRADS V.2 based score.
    Jyoti R; Jina NH; Haxhimolla HZ
    J Med Imaging Radiat Oncol; 2017 Apr; 61(2):212-215. PubMed ID: 27987276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.